Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · IEX Real-Time Price · USD
1.09
-0.07 (-6.03%)
At close: Dec 8, 2023, 4:00 PM
1.11
+0.02 (1.83%)
After-hours: Dec 8, 2023, 7:30 PM EST
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $68.03 million as of December 8, 2023. Its market cap has decreased by -6.56% in one year.
Market Cap
68.03M
Enterprise Value
81.02M
1-Year Change
-6.56%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from $142.00M to $68.03M, a decrease of -52.09%. That is a compound annual growth rate of -9.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 7, 2023 | 72.40M | - |
Dec 6, 2023 | 72.40M | 4.47% |
Dec 5, 2023 | 69.30M | -0.86% |
Dec 4, 2023 | 69.90M | 8.71% |
Dec 1, 2023 | 64.30M | 2.06% |
Nov 30, 2023 | 63.00M | - |
Nov 29, 2023 | 63.00M | -2.02% |
Nov 28, 2023 | 64.30M | 2.06% |
Nov 27, 2023 | 63.00M | - |
Nov 24, 2023 | 63.00M | 0.96% |
Nov 22, 2023 | 62.40M | 5.23% |
Nov 21, 2023 | 59.30M | -2.31% |
Nov 20, 2023 | 60.70M | 2.02% |
Nov 17, 2023 | 59.50M | 3.48% |
Nov 16, 2023 | 57.50M | -4.01% |
Nov 15, 2023 | 59.90M | 1.18% |
Nov 14, 2023 | 59.20M | -2.15% |
Nov 13, 2023 | 60.50M | 0.83% |
Nov 10, 2023 | 60.00M | 16.05% |
Nov 9, 2023 | 51.70M | -19.09% |
Nov 8, 2023 | 63.90M | -9.62% |
Nov 7, 2023 | 70.70M | - |
Nov 6, 2023 | 70.70M | 19.43% |
Nov 3, 2023 | 59.20M | 19.35% |
Nov 2, 2023 | 49.60M | 4.86% |
View and export this data all the way back to 2016.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Leap Therapeutics | 69.54M |
Asensus Surgical | 69.28M |
Personalis | 69.13M |
Atara Biotherapeutics | 68.34M |
Cara Therapeutics | 68.10M |
Curis | 67.86M |
Champions Oncology | 66.99M |
Cidara Therapeutics | 66.91M |